A study analyzing cross-Resistance to Lenacapavir in Hiv Entry Inhibitor-Resistant Isolates
Latest Information Update: 25 Mar 2022
At a glance
- Drugs Lenacapavir (Primary) ; Enfuvirtide; Fostemsavir; Ibalizumab; Maraviroc
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 25 Mar 2022 New trial record
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections